Group 1 - The article discusses the mixed performance of major stock indexes, including the Dow Jones Industrial Average, amid concerns over bad loans on Wall Street [1] - Eli Lilly (LLY) and Novo Nordisk (NVO) experienced stock declines following comments from President Donald Trump regarding weight-loss drug pricing [1] - Eli Lilly is focusing on growth and sustainability through a strong drug pipeline, revenue growth, and energy investments [2] Group 2 - The stock market is influenced by fears related to bank stability, with notable declines in stocks such as Oracle and Interactive Brokers [4] - Omeros saw a significant stock increase of 154% due to a surprise $2.1 billion deal with Novo Nordisk [4]